Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hombach

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of Clinical Microbiology|April 19, 2013
Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 antimicrobial susceptibility testing guidelines on multidrug resistance rates of Gram-negative rodsMichael Hombach, Aline Wolfensberger, Stefan P Kuster, et al.
Journal of Clinical Microbiology|August 8, 2014
Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?Florian P Maurer, Patrice Courvalin, Erik C Böttger, et al.
Journal of Clinical Microbiology|October 2, 2015
Evaluation of the Rapidec Carba NP Test for Detection of Carbapenemases in EnterobacteriaceaeMichael Hombach, Barbara von Gunten, Claudio Castelberg, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiSTKatja Lucke, Michael Hombach, Ute Friedel, et al.
Journal of Medical Microbiology|October 23, 2010
Human infection with Delftia tsuruhatensis isolated from a central venous catheterBenjamin Preiswerk, Silvia Ullrich, Rudolf Speich, et al.
Antimicrobial Resistance and Infection Control|December 5, 2019
The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rodsAline Wolfensberger, Stefan P Kuster, Martina Marchesi, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2011
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolatesSilke Polsfuss, Guido V Bloemberg, Jacqueline Giger, et al.
International Journal of Medical Microbiology : IJMM|May 22, 2013
Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiSTMichael Hombach, Akos Somoskövi, Rico Hömke, et al.
Journal of Clinical Microbiology|January 24, 2014
Evaluation of the Bruker MALDI Biotyper for identification of Gram-positive rods: development of a diagnostic algorithm for the clinical laboratoryBettina Schulthess, Guido V Bloemberg, Reinhard Zbinden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 18, 2001
Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream eventsIwan Walev, Michael Hombach, Wieslawa Bobkiewicz, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Microbiology|April 19, 2013
Influence of clinical breakpoint changes from CLSI 2009 to EUCAST 2011 antimicrobial susceptibility testing guidelines on multidrug resistance rates of Gram-negative rodsMichael Hombach, Aline Wolfensberger, Stefan P Kuster, et al.
Journal of Clinical Microbiology|August 8, 2014
Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?Florian P Maurer, Patrice Courvalin, Erik C Böttger, et al.
Journal of Clinical Microbiology|October 2, 2015
Evaluation of the Rapidec Carba NP Test for Detection of Carbapenemases in EnterobacteriaceaeMichael Hombach, Barbara von Gunten, Claudio Castelberg, et al.
The Journal of Antimicrobial Chemotherapy|October 4, 2011
Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiSTKatja Lucke, Michael Hombach, Ute Friedel, et al.
Journal of Medical Microbiology|October 23, 2010
Human infection with Delftia tsuruhatensis isolated from a central venous catheterBenjamin Preiswerk, Silvia Ullrich, Rudolf Speich, et al.
Antimicrobial Resistance and Infection Control|December 5, 2019
The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rodsAline Wolfensberger, Stefan P Kuster, Martina Marchesi, et al.
The Journal of Antimicrobial Chemotherapy|October 6, 2011
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolatesSilke Polsfuss, Guido V Bloemberg, Jacqueline Giger, et al.
International Journal of Medical Microbiology : IJMM|May 22, 2013
Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiSTMichael Hombach, Akos Somoskövi, Rico Hömke, et al.
Journal of Clinical Microbiology|January 24, 2014
Evaluation of the Bruker MALDI Biotyper for identification of Gram-positive rods: development of a diagnostic algorithm for the clinical laboratoryBettina Schulthess, Guido V Bloemberg, Reinhard Zbinden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 18, 2001
Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream eventsIwan Walev, Michael Hombach, Wieslawa Bobkiewicz, et al.
Pageof 5